Dorothy J. Margolskee

Statistics

Publications

Citations

977

H-Index

Active since

1988

Affiliations

Merck Institute for Science Education(Current)

United States Military Academy

MSD (Belgium)

Merck & Co., Inc., Rahway, NJ, USA (United States)

KU Leuven

Dorothy J. Margolskee is an author at Merck Institute for Science Education specializing in pharmacology, leukotriene pharmacology, and pharmacodynamics.

Publications per year

1988–1995

Publications

Inhibition of Exercise-Induced Bronchoconstriction by MK-571, a Potent Leukotriene D<sub>4</sub>–Receptor Antagonist

Patrick Manning, Richard M. Watson, Dorothy J. Margolskee et al. · New England Journal of Medicine · 1990 · 401 citations · Full text

Life Sciences, Pharmacology, Exercise Physiology +8

Bronchodilation with a Potent and Selective Leukotriene D4 (LTD4) Receptor Antagonist (MK-571) in Patients with Asthma

Joseph N. Gaddy, Dorothy J. Margolskee, Robert K. Bush et al. · American Review of Respiratory Disease · 1992 · 141 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects.

Barbro Dahlén, Dorothy J. Margolskee, O. Zetterström · Thorax · 1993 · 116 citations · Full text

Medicine, Pharmacology, Physiology +17

Single dose pharmacokinetics, safety and tolerability of MK‐0476, a new leukotriene D4‐receptor antagonist, in healthy volunteers.

DF Schoors, M. De Smet, Theodore F. Reiss et al. · British Journal of Clinical Pharmacology · 1995 · 68 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

MK-571, a Potent Antagonist of Leukotriene D4-induced Bronchoconstriction in the Human

Johan Kips, G.F. Joos, Inge De Lepeleire et al. · American Review of Respiratory Disease · 1991 · 68 citations

Medicine, Pharmacology, Pharmacotherapy +14

1–5 of 12